Role of Gut Microbiota in the Pathophysiology of Aseptic Abscesses

Status: Recruiting
Location: See all (15) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Aseptic abscess syndrome (AA) is a rare entity characterized by the occurrence of deep abscesses with no germ found. Antibiotic therapy is ineffective and they are sensitive to anti-inflammatory treatment with corticosteroids. Gut microbiota is important for the development of the immune system. In Crohn's disease which is frequently associated with AA syndrome, dysbiosis is found but could also be involved in the immune response at a distance from the gut. Stool, blood, saliva and urine samples will be taken from the patients included and their controls in the centers where they are followed. These biological samples will be transported to Clermont Ferrand using the same procedure (transporter and dry ice) where the following analyses will be performed: microbiota on stool and saliva, short chain fatty acids on stool and lymphocyte study on blood.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• For cases: adult patients meeting the diagnostic criteria for aseptic abscess syndrome described by André et al:

• Deep abscesses on radiological examination with neutrophilic features proven by pathological analysis of a surgical specimen or biopsy when performed

• Negative blood cultures, negative serological tests for bacteria, including always Yersinia enterocolitica, and, during surgery or aspiration, sterile pus (with standard cultures, BAAR and fungal tests) Failure of antibiotic therapy, when prescribed, after at least 2 weeks for conventional antibiotic therapy and at least 3 months for anti-tuberculosis treatment

• Rapid clinical improvement the day after the prescription of corticosteroids (at least 1/2 mg/kg prednisone or equivalent) followed by radiological improvement after 1 month of corticosteroids, sometimes in association with immunosuppressive treatments.

⁃ For controls: adult person living in the same environment as the case to which it is matched. Adult person living in the same household or near the patient.

⁃ For cases and controls:

• Ability to provide informed consent.

• Membership in the Social Security system.

Locations
Other Locations
France
CHU de Bordeaux
RECRUITING
Bordeaux
Centre Hospitalier Intercommunal Nord-Ardennes
RECRUITING
Charleville-mézières
CHU de Clermont-Ferrand
RECRUITING
Clermont-ferrand
CHU Henri Mondor - Assistance Publique -Hôpitaux de Paris (AP-HP)
RECRUITING
Créteil
Centre Hospitalier de Dax
RECRUITING
Dax
Centre Hospitalier Saint Joseph Saint Luc
RECRUITING
Lyon
Hospices Civils de Lyon
RECRUITING
Lyon
Assistance Publique - Hôpitaux de Marseille (AP-HM)
RECRUITING
Marseille
CHU de Montpellier
RECRUITING
Montpellier
CHU de Nantes
RECRUITING
Nantes
CHU de Nimes
RECRUITING
Nîmes
Hôpital Cochin - Assistance Publique -Hôpitaux de Paris (AP-HP)
RECRUITING
Paris
Hôpital La Pitié-Salpétrière - Assistance Publique -Hôpitaux de Paris (AP-HP)
RECRUITING
Paris
Hôpital Louis Mourier - Assistance Publique -Hôpitaux de Paris (AP-HP)
RECRUITING
Paris
Hôpital Saint Louis Lariboisière - Assistance Publique -Hôpitaux de Paris (AP-HP)
RECRUITING
Paris
Contact Information
Primary
Lise Laclautre, PharmD
promo_interne_drci@chu-clermontferrand.fr
04 73 754 963
Backup
Trefond Ludovic, MD
promo_interne_drci@chu-clermontferrand.fr
Time Frame
Start Date: 2021-09-07
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 60
Treatments
Experimental: Patients
adult patients with aseptic abscess syndrome
Experimental: control
control An adult person living in the same environment as the case.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Clermont-Ferrand

This content was sourced from clinicaltrials.gov